Kimiara News
Morning event of Forimo painkillers at Imam Khomeini Hospital in Tehran
Kimiara company participated in pain morning which was held on Monday 31th July of 2023 for a group of Tehran medical sciences University pain professors
Scientific morning in the Nephrology and Rheumatology department of Shariati Hospital in Tehran, with the topic of introduction and review of mycophenolate mofetil and mycophenolate sodium (MOFECON)
Mofecon brand is a product of Concord Biotech Company, which is one of the most reliable companies producing immunosuppressive drugs. Quality and bioequivalence studies of Mofecon
Scientific morning in the Nephrology department of Montaserieh Hospital in Mashhad, with the topic of introduction and review of mycophenolate mofetil and mycophenolate sodium (MOFECON)
Mofecon brand is a product of Concord Biotech Company, which is one of the most reliable companies producing immunosuppressive drugs. Quality and bioequivalence studies of
Participation of Kimiara company in the 33rd annual congress of the society of internal medicine specialists of Iran since 13-16th of June 2023, at the Razi Conference Center of Iran Medical Sciences University .
Participation of Kimiara company in the 33rd annual congress of the society of internal medicine specialists of Iran since 13-16th of June 2023, at the
Kimiara company in the 9th annual rheumatology seminar in memory of Professor Mohammad Shafizadeh at the conference center of Tehran Industrial Management Institute
Kimiara company has participated in the 9th Annual Rheumatology Seminar which is held on 15_ 16th June of 2023 in memory of Professor Mohammad Shafizadeh
Scientific morning in the Nephrology department of Labafinejad Hospital in Tehran, with the topic of introduction and review of mycophenolate mofetil and mycophenolate sodium (MOFECON)
Mofecon brand is a product of Concord Biotech Company, which is one of the most reliable companies producing immunosuppressive drugs. Quality and bioequivalence studies of
